PROCEPT BioRobotics recently reported two major milestones in its WATER IV prostate cancer program, completing enrollment in the randomized WATER IV RP trial comparing Aquablation therapy with radical ...

PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: ...

SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...

(HealthDay News) — The Aquablation water-based surgical procedure is safe and effective for use with enlarged prostates compared with laser surgery, according to a study presented at the 40th annual ...

SAN JOSE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (PRCT) ® Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative ...

CHI Memorial announces it is the first in the Chattanooga region to offer Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), or ...

Benign prostatic hyperplasia (BPH) is a non-cancerous prostate tissue growth affecting men 40 and older. BPH can cause difficulty urinating and may be exacerbated by some cold and allergy medications.

For an estimated one in two men aged 51 to 60, benign prostatic hyperplasia (BPH), or an enlarged prostate, is the number one reason they visit the urologist. Risk factors for BPH include aging, ...

A new procedure at North Colorado Medical Center in Greeley is helping men with a common medical issue as they age. While stress incontinence is a common issue in women‚ leading to urinary leakage ...

Using a high-pressure water jet to operate on an enlarged prostate can better preserve the ability to ejaculate, compared with standard laser surgery, finds research. The technique has similar ...